Raphas Co., Ltd. (KOSDAQ:214260)

Market Cap	121.92B
Revenue (ttm)	28.85B
Net Income (ttm)	-7.84B
Shares Out	8.41M
EPS (ttm)	-906.25
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,629
Average Volume	12,278
Open	14,900
Previous Close	14,810
Day's Range	14,500 - 14,940
52-Week Range	12,500 - 22,500
Beta	1.24
RSI	45.28
Earnings Date	Nov 14, 2025

About Raphas

Raphas Co., Ltd. manufactures and sells biodegradable microneedles in Korea. The company offers skin care, medical device, whitening care, and wrinkle care under the Acropass brand; and health food product under the FitKong brand. It also supplies double-layer microneedle manufacturing technology; and provides original development manufacturing, and contract development and manufacturing organization services. The company was founded in 2006 and is headquartered in Seoul, South Korea.

• Industry: Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 2006
• Employees: 79
• Stock Exchange: KOSDAQ
• Ticker Symbol: 214260

Financial Performance

In 2024, Raphas's revenue was 27.22 billion, a decrease of -2.58% compared to the previous year's 27.94 billion. Losses were -4.77 billion, -45.80% less than in 2023.